Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction | MicrobiomeTrials← Back to trialsNCT00365157
Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2006-10-23Est. Completion: 2025-07-09
Enrollment target: 168 participants Locations- Tower Cancer Research Foundation, Beverly Hills, California, United States
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
- City of Hope Antelope Valley, Lancaster, California, United States
- USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
- Contra Costa Regional Medical Center, Martinez, California, United States
- Veterans Administration Hospital - Martinez, Martinez, California, United States
- University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
- City of Hope South Pasadena, South Pasadena, California, United States
- University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
- Decatur Memorial Hospital, Decatur, Illinois, United States
- NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, United States
- Ingalls Memorial Hospital, Harvey, Illinois, United States
- Duly Health and Care Joliet, Joliet, Illinois, United States
- Loyola University Medical Center, Maywood, Illinois, United States
Other microbiome trials you might be interested in
Malignant Germ Cell TumorLung AdenocarcinomaGastric/Esophageal/Gastroesophageal Junction (GEJ) AdenocarcinomaUrothelial CarcinomaEndometrial AdenocarcinomaOvarian Adenocarcinoma
DBC-664-ONC-101 is a first-in-human Phase 1a/1b open-label, multicenter study to evaluate the safety, tolerability, PK, …
Denver, United StatesEst. completion Apr 1, 2030
Metastatic Urothelial CarcinomaUrothelial CancerUrothelial Carcinoma
Illinois CancerCare-Peoria, Peoria, Illinois, United StatesCentral Illinois Hematology Oncology Center, Springfield, Illinois, United StatesSouthern Illinois University School of Medicine, Springfield, Illinois, United StatesFort Wayne Medical Oncology and Hematology Inc-Parkview, Fort Wayne, Indiana, United StatesCommunity Howard Regional Health, Kokomo, Indiana, United StatesNorthern Indiana Cancer Research Consortium, South Bend, Indiana, United StatesUniversity of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United StatesWayne State University/Karmanos Cancer Institute, Detroit, Michigan, United StatesOncology Care Associates PLLC, Saint Joseph, Michigan, United StatesMercy Hospital Saint Louis, St Louis, Missouri, United StatesUPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United StatesMedical College of Wisconsin, Milwaukee, Wisconsin, United StatesLocally Advanced or Metastatic Urothelial Carcinoma
Bladder Cancer
Bladder Neoplasms
Bladder Tumors
Cancer of Bladder
Cancer of the Bladder
Malignant Tumor of Urinary Bladder
Neoplasms, Bladder
Urinary Bladder Cancer
Bladder cancer (urothelial carcinoma) is a disease where cells in the bladder grow out of control. The bladder is an org…
Multiple LocationsEst. completion Apr 1, 2027